Scott E Delacroix Jr M.D.

Radical Cystectomy shouldn't be the only conversation after EV-Pembro.

@HimanshuNagarMD @NiuSanford @NRGonc @drjefstathiou @SeanSachdevMD @shilpaonc @IyerGopa @l_ballas @Dr_Aggen @MiyamotoDavid @AdityaBagrodia @ndesai2005 I called it an Ice-ee for a reason :)

Had a great time on this @NRGonc podcast...from discussing bladder preservation to the Slurpee analogy of RT fractionation...tune in to find out more. #BCAN26TT @drjefstathiou @SeanSachdevMD @shilpaonc @IyerGopa @l_ballas @Dr_Aggen @MiyamotoDavid @AdityaBagrodia @ndesai2005 @jonathan_leeman @abhiAsolanki @KashaniRojano @KateMRGuidance @Katie_Spina @DrPaulNguyen

New on the NRG Oncology Podcast: Study PIs @UroCancer & @HimanshuNagarMD discuss the ARCHER trial, including the study's design, eligibility, & the research questions behind shorter-course adaptive radiation for muscle-invasive #BladderCancer. Listen now! NRGOncology.org

US rivers drawn in proportion to how much water they carry

Bertha has Lake Pontchartrain movin

Excited 4 the inaugural #FUO26 with SUO Leadership supporting a 3 day symposium to share what a career w/in the @UroOnc provides Interactive discussions, dz focused sessions, career develop. opportunities + an intro to a community focused on Ca biology and multi-D treatment

@MaxKates Cajun trialist: If you aren’t careful, you will design the “perfect trial”….

The clinical trialists creed: Hubris is the enemy of progress.

@TylerSbrt @HimanshuNagarMD @Xristodouleas @mr_linac @NRGonc @NiuSanford

@HimanshuNagarMD @UroCancer @Xristodouleas @mr_linac @NRGonc @NiuSanford Dating yourself is one of the surest ways to get broken up with. No relationship can survive without at least a little time apart.

Hey @mr_linac , it's @NRGonc week! Considering #LAP100 for pancreas cancer or #ARCHER for bladder cancer, but hesitant about the "big doses"? Join @NiuSanford, @HimanshuNagarMD and Thomas Banks next week for a Knowledge Exchange Webinar and learn the practical strategies, planning tips, and lessons learned to implement these trials with confidence. #MRLinac #NRG-GI011, #NRG-GU015. @adapthyun @UTSW_RadOnc @MSK_RadOnc @UroCancer @whallradonc @MikeChuongMD

@CanesDavid Most important second opinion sometimes that patients never think of ….pathology second opinion. The reports that patients walk in the door with sometimes….

Does anything signal the need pathology second opinion quite like Gleason 3+5=8?

@CanesDavid This was a good one I saw in the last 6 months… “small amount of carcinoma favor Gleason 4+4”…..

@CanesDavid T1 low grade with CIS…. Run run run.

@CanesDavid 3+3=6 all cores and greater than 6mm/core.

DO NOT TRAVEL for the next hour or two in NOLA. Flooding is significant on streets. Your car isn’t a boat folks! 📸 Audrey Baldo #lawx

@TylerSbrt @scserendipity1 @UroDocAsh @DrYukselUrun @MedwatchKate @OncoAlert @OpenMedicineHQ @Uromigos @shilpaonc @tompowles1 @brian_rini @AlisonBirtle @HimanshuNagarMD If you are in the US, and have received EV-P but don’t want to proceed with removal of your bladder—ask about ARCHER or BRIGHT. There are other clinical trial options. These two trials combined n=597. @NRGonc @SWOG

@TylerSbrt @scserendipity1 @UroDocAsh @DrYukselUrun @MedwatchKate @OncoAlert @OpenMedicineHQ @Uromigos @shilpaonc @tompowles1 @brian_rini @AlisonBirtle @HimanshuNagarMD One very reasonable option is Archer or Bright. Trials have gotten us here and will provide clarity forward. When you explain the options, patients are thankful to have the next generation of trials.

After 4 cycles of neoadj enfortumab vedotin/pembro in a patient with cT3N0 muscle-invasive bladder cancer, the patient no longer wishes to undergo surgery. What would be your next? @OncoAlert @OpenMedicineHQ @Uromigos

NRG-GU015 (ARCHER) opened to accrual in August 2025 and is recruiting patients with invasive muscle bladder cancer who would like to avoid surgery to remove the bladder. Learn more 🏹nrgoncology.org/ARCHER @UroCancer @HimanshuNagarMD

@alantanmd @DrRanaMcKay @EAntonarakis @neerajaiims @AzadOncology @CParkMD @APCCC_Lugano @TDorffOnc @_backtableUro @DrChoueiri @Daniel_J_George @DrYukselUrun @VUMCDiscoveries Nomenclature adoption seems to be split in talking to experts and patients. Telling men they have a disease called (a)PMS…..

Our final episode is out! We recorded 3 podcasts addressing PARP in prostate cancer. You’ll definitely want to listen to this one with @DrRanaMcKay UC San Diego Moores Cancer Center and @EAntonarakis Masonic Cancer Center, University of Minnesota I really enjoyed this one. One recurring theme, germline and somatic testing must be done to optimally manage our patients with advanced prostate cancer. Also nice discussion on the transition from HSPC/CRPC to APMS/APMR in PCWG4. Watch the full episode here: youtu.be/CMXtFQPp35c?is… Get app and Listen here: na2.hubs.ly/H06x3F60

NRG-GU014 (PARRC): This trial is recruiting patients with non-muscle invasive bladder cancer. Learn more ↪️ow.ly/nFVu50ZlaQG @BrianBaumannMD @UroCancer

Ha!

As we celebrate 250 years of our country, we also celebrate that 4th of July when Terry did NOT put it in reverse!!! 🇺🇸😂 #legend #4thofJuly